Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-203

I beg to disagree that realistically, nothing has changed. For one, instead of having to wonder if IMU is on the radar of BP, well, wonder no more. IMU is on the radar of BP.

Secondly, with the likes of Merck and Pfizer involved here, it also validates the reputation of IMU to all other big pharma. After all, no big pharma will want to risk their reputation by being involved with a fly by night operation. This collaboration validates IMU's management quality. After all, without great management, there can be no great company. This collaboration will also make it easier for future collaboration with other big pharma. One will lead to two and two will lead to three and so on.

I am sure there are more points to be made, but I think I made my point.